The Selective Metabotropic Glutamate 2/3 Receptor Agonist MG50028 Reverses Isolation Rearing Induced Abnormal Behaviors in Mice

被引:26
作者
Ago, Yukio [1 ]
Araki, Ryota [1 ]
Yano, Koji [1 ]
Kawasaki, Toshiyuki [3 ]
Chaki, Shigeyuki [4 ]
Nakazato, Atsuro [5 ]
Onoe, Hirotaka [3 ]
Hashimoto, Hitoshi [2 ,6 ,7 ,8 ]
Baba, Akemichi [2 ,9 ]
Takuma, Kazuhiro [1 ]
Matsuda, Toshio [1 ,6 ,7 ]
机构
[1] Osaka Univ, Grad Sch Pharmaceut Sci, Lab Med Pharmacol, Suita, Osaka 5650871, Japan
[2] Osaka Univ, Grad Sch Pharmaceut Sci, Lab Mol Neuropharmacol, Suita, Osaka 5650871, Japan
[3] Kobe MI R&D Ctr, Ctr Mol Imaging Sci, RIKEN, Funct Probe Res Lab,Chuo Ku, Kobe, Hyogo 6500047, Japan
[4] Taisho Pharmaceut Co Ltd, Mol Funct & Pharmacol Labs, Kita Ku, Saitama 3319530, Japan
[5] Taisho Pharmaceut Co Ltd, R&D Headquarters Pharmaceut Operat, Strateg Planning Drug Discovery, Kita Ku, Saitama 3319530, Japan
[6] Kanazawa Univ, Osaka Univ, United Grad Sch Child Dev, Suita, Osaka 5650871, Japan
[7] Osaka Univ, Hamamatsu Univ Sch Med, Suita, Osaka 5650871, Japan
[8] Osaka Univ, Grad Sch Med, Dept Mol Pharmaceut Sci, Suita, Osaka 5650871, Japan
[9] Hyogo Univ Hlth Sci, Chuo Ku, Kobe, Hyogo 6508530, Japan
关键词
metabotropic glutamate 2/3 receptor; isolation rearing; behavior; WEANING SOCIAL-ISOLATION; SCHIZOPHRENIA; PHENCYCLIDINE; PHASE-2; DRUG;
D O I
10.1254/jphs.11200SC
中图分类号
R9 [药学];
学科分类号
100702 [药剂学];
摘要
Isolation-induced abnormal behaviors are useful animal models for assessing potential anti-psychotic drugs. This study examined the effect of MGS0028, a selective metabotropic glutamate 2/3 receptor agonist, on abnormal behaviors such as hyperactivity, aggression, and deficits of prepulse inhibition in isolation-reared mice. MGS0028 attenuated hyperactivity and aggressive behaviors in isolation-reared mice. The agonist also reversed isolation rearing induced deficits of prepulse inhibition. On the other hand, MGS0028 did not affect locomotor activity and prepulse inhibition in group-reared mice. These results suggest that the metabotropic glutamate 2/3 receptor agonist, MGS0028, is a potential compound for the treatment of psychiatric disorders.
引用
收藏
页码:295 / 298
页数:4
相关论文
共 16 条
[1]
Activation of metabotropic glutamate 2/3 receptors attenuates methamphetamine-induced hyperlocomotion and increase in prefrontal serotonergic neurotransmission [J].
Ago, Yukio ;
Araki, Ryota ;
Yano, Koji ;
Hiramatsu, Naoki ;
Kawasaki, Toshiyuki ;
Chaki, Shigeyuki ;
Nakazato, Atsuro ;
Onoe, Hirotaka ;
Hashimoto, Hitoshi ;
Baba, Akemichi ;
Takuma, Kazuhiro ;
Matsuda, Toshio .
PSYCHOPHARMACOLOGY, 2011, 217 (03) :443-452
[2]
Pharmacological Aspects of the Acetylcholinesterase Inhibitor Galantamine [J].
Ago, Yukio ;
Koda, Ken ;
Takuma, Kazuhiro ;
Matsuda, Toshio .
JOURNAL OF PHARMACOLOGICAL SCIENCES, 2011, 116 (01) :6-17
[3]
Group II metabotropic glutamate receptor agonists as a potential drug for schizophrenia [J].
Chaki, Shigeyuki .
EUROPEAN JOURNAL OF PHARMACOLOGY, 2010, 639 (1-3) :59-66
[4]
Behavioural and neurochemical effects of post-weaning social isolation in rodents - Relevance to developmental neuropsychiatric disorders [J].
Fone, Kevin C. F. ;
Porkess, M. Veronica .
NEUROSCIENCE AND BIOBEHAVIORAL REVIEWS, 2008, 32 (06) :1087-1102
[5]
Identification of a serotonin/glutamate receptor complex implicated in psychosis [J].
Gonzalez-Maeso, Javier ;
Ang, Rosalind L. ;
Yuen, Tony ;
Chan, Pokman ;
Weisstaub, Noelia V. ;
Lopez-Gimenez, Juan F. ;
Zhou, Mingming ;
Okawa, Yuuya ;
Callado, Luis F. ;
Milligan, Graeme ;
Gingrich, Jay A. ;
Filizola, Marta ;
Meana, J. Javier ;
Sealfon, Stuart C. .
NATURE, 2008, 452 (7183) :93-U9
[6]
The mGluR2/3 agonist LY379268 reverses post-weaning social isolation-induced recognition memory deficits in the rat [J].
Jones, Caitlin A. ;
Brown, Angus M. ;
Auer, Dorothee P. ;
Fone, Kevin. C. F. .
PSYCHOPHARMACOLOGY, 2011, 214 (01) :269-283
[7]
Increased binding of cortical and hippocampal group II metabotropic glutamate receptors in isolation-reared mice [J].
Kawasaki, Toshiyuki ;
Ago, Yukio ;
Yano, Koji ;
Araki, Ryota ;
Washida, Yusuke ;
Onoe, Hirotaka ;
Chaki, Shigeyuki ;
Nakazato, Atsuro ;
Hashimoto, Hitoshi ;
Baba, Akemichi ;
Takuma, Kazuhiro ;
Matsuda, Toshio .
NEUROPHARMACOLOGY, 2011, 60 (2-3) :397-404
[8]
A Multicenter, Inpatient, Phase 2, Double-Blind, Placebo-Controlled Dose-Ranging Study of LY2140023 Monohydrate in Patients With DSM-IV Schizophrenia [J].
Kinon, Bruce J. ;
Zhang, Lu ;
Millen, Brian A. ;
Osuntokun, Olawale O. ;
Williams, Judy E. ;
Kollack-Walker, Sara ;
Jackson, Kimberley ;
Kryzhanovskaya, Ludmila ;
Jarkova, Natalia .
JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY, 2011, 31 (03) :349-355
[9]
Marek GJ, 2000, J PHARMACOL EXP THER, V292, P76
[10]
Millan MJ, 1999, J PHARMACOL EXP THER, V288, P1002